𝗔𝗻𝗻𝗼𝘂𝗻𝗰𝗶𝗻𝗴 𝗠𝗲𝘁𝗿𝗶𝗰 𝗧𝗲𝘅𝗮𝘀 – 𝗼𝘂𝗿 𝗯𝗿𝗮𝗻𝗱-𝗻𝗲𝘄 𝗼𝗳𝗳𝗶𝗰𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗵𝗲𝗮𝗿𝘁 𝗼𝗳 𝗔𝘂𝘀𝘁𝗶𝗻. As we continue to increase our footprint across the US as part of our private equity investment from BGF, we look forward to bringing Metric directly to our partners, creating opportunities to meet face-to-face and embed ourselves in the community we partner with directly. Heading up our Texas office will be Jonathan McManus, alongside Christopher Perez, both with an impressive track record of providing talent solutions within Texas and surrounding Southern states. If you’re a business based in Texas looking to partner with one of the world’s fastest-growing recruitment firms, be sure to reach out to Jonathan McManus or visit our website for more information. https://lnkd.in/dMXRZgxh #Metric #Recruitment #Texas #Austin
About us
Utilizing our expertise to provide recruitment solutions to some of the worlds most cutting-edge companies in MedTech and Life Science. Our world-leading team of expert’s passion lies in deliver cutting edge talent solutions to visionary clients, positively impacting human health within a variety of specialisms including: - Biotech - CDMO - CRO - MedTech New York | London | Florida | Nottingham
- Website
-
http://www.metric-search.com
External link for Metric Bio
- Industry
- Staffing and Recruiting
- Company size
- 51-200 employees
- Headquarters
- New York
- Type
- Privately Held
- Specialties
- Biotech , Genomics, Lab Automation, Cell & Gene Therapy, Cellular Agriculture, CDMO, Biologics, Drug Products, API, CRO, Pre-Clinical, Clinical, E-Clinical, Clinical Trial Supply, Drug Discovery, Digital Health, HealthTech, Artificial Intelligence, SaaS, Telemedicine, MedTech, Neurotech, FemTech, Cardiovascular, Medical Imagine & AI, Surgical Robotics, Orthopaedic and Spine, Pharma, and Molecular Diagnostics
Locations
-
Primary
New York, US
-
Fort Lauderdale, US
-
London, GB
-
Nottingham, GB
Employees at Metric Bio
Updates
-
Today, we join the country in celebrating Labor Day - a moment to honor the achievements of workers across all industries. To every professional, your commitment and creativity are the driving forces behind our progress. As we enjoy this well-deserved break, let’s reflect on the collective effort that shapes our workplaces and communities. Here’s to the teamwork and resilience that define your industry. Wishing everyone a relaxing and joyful Labor Day! #MetricBio #LaborDay #Teamwork #Appreciation
-
-
Our Talent Acquisition specialists provide you with some of the most highly sought-after job roles available. Read below about Caitlin James, our Senior Business Development Lead, and her recent placements in the MedTech space. Her success is a testament to her industry knowledge and hard work. Why not visit her webpage to learn more? https://lnkd.in/ed52_4EK #MetricBio #Recruitment #RecentRoles #Medtech
-
-
Communication is key for any job search. At Metric Bio, we value our partners and pride ourselves on maintaining clear and open lines of communication, ensuring that you are always well-informed. Billy Williams, our Senior Business Development Lead and specialist in Radiology and Surgical AI, goes above and beyond to ensure you remain informed throughout your entire experience with Metric Bio. Read below about Francesca Evans’ experience with Billy and visit his webpage to learn more about his partnerships. https://lnkd.in/ez_NMyN3 #MetricBio #Recruitment #Communication #Radiology #SurgicalAI
-
Johnson & Johnson's have a definitive agreement to acquire V-Wave, a pioneering company dedicated to developing innovative treatment options for heart failure. This strategic acquisition will enhance Johnson & Johnson's position as a leader in cardiovascular care and accelerate their mission to address some of the most pressing global health challenges. V-Wave's cutting-edge Ventura® Interatrial Shunt technology targets heart failure with reduced ejection fraction (HFrEF), a condition affecting millions of patients worldwide. With the potential to be the first device of its kind to market, this minimally invasive implant could significantly improve patient outcomes and fill a critical treatment gap. This acquisition underscores Johnson & Johnson's commitment to expand into high-growth markets, deepening their relationships with heart failure specialists. Read more about this exciting milestone in transforming cardiovascular care below! https://lnkd.in/eVPgC_Zb #MetricBio #Recruitment #HealthcareInnovation #CardiovascularCare #HeartHealth #JohnsonAndJohnson
-
Are you looking for a new challenge? At Metric Bio, we offer a wide range of positions available worldwide. Why not visit our jobs page today and see where your career change could take you? https://lnkd.in/ePKhSeEP #MetricBio #Recruitment #NewRoles #WorldWide #CareerJourney
-
-
Are you looking to relocate? We offer roles all around the world. In the CDMO and CRO industries, our most sought-after positions are in California where we offer a variety of opportunities. Why not visit our jobs page today and join many of our industry-leading partners in California? Read below about some of our previous and current roles to see where your career journey could take you. https://lnkd.in/dSZ2fyyi #MetricBio #Recruitment #California #CDMO #CRO
-
At Metric Bio, our talent acquisition specialists put your needs first, ensuring you have the best possible experience throughout your career journey. Our expert in the SaaS Health Tech and Life Sciences industries, and Business Development Lead, Caroline Graves, is dedicated to helping you get the most out of your career through fostering trusted relationships with her partners. Read below about Naif Zaman, Ph.D.’s experience with Caroline and visit her webpage to learn more. https://lnkd.in/enzPzyUC #MetricBio #Recruitment #CareerJourney #HealtTech #LifeScience
-
-
Future Market Insights (FMI) has unveiled its latest industry analysis, revealing a promising trajectory for the global sterile injectable CDMO market. The market, valued at approximately $10.1 billion in 2023, is expected to soar to $33.7 billion by 2034 with a Compound Annual Growth Rate of 11.7%. This highlights the burgeoning opportunities within the sector. The industry is shifting towards an end-to-end business model, offering comprehensive services from API development to finished drug products. This change meets the rising demand for faster development and market readiness, especially in the biologics sector. Read more about this market surge below https://lnkd.in/eRsFkPHn #MetricBio #Recruitment #CDMO #MarketGrowth #Pharmaceuticals
Global Sterile Injectable CDMO Market Projected to Surge to USD 33.7 Billion by 2034, Exhibiting a 11.7% CAGR - FMIBlog
https://www.fmiblog.com
-
On the hunt for a new role? Check out our jobs page and connect with our world-class talent acquisition specialists. We're here to support you on your career journey and help you find the perfect opportunity. https://lnkd.in/ePKhSeEP #MetricBio #CurrentRole #NewRoles
-